To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.
By retrospectively analyzing the clinical epidemiological characteristics of the novel
coronavirus pneumonia and the current diagnosis and treatment schemes, as well as in-depth
analyzing the disease development process and outcome trends of NCP patients to develop
practical and effective clinical diagnosis and treatment schemes and provide guarantee for
the rapid control of the epidemic.
Combination Product: systemic treatment
Oxygen therapy, antiviral therapy, antibiotics, hormones, globulin
Inclusion Criteria:
- Patients confirmed with novel coronavirus pneumonia. The Diagnostic criteria refer to
"Pneumonitis Diagnosis and Treatment Scheme for Novel Coronavirus Infection (Trial
Version 5)";
Exclusion Criteria:
- Physician judged the patient was not suitable for this clinical trial.
Union hospital
Wuhan, Hubei, China
Investigator: Yang Jin
Contact: 13554361146
whuhjy@126.com
Yang Jin
13554361146
whunjy@126.com
Jiancai Wu
02785726685